Back to top
more

Dynavax Technologies (DVAX)

(Delayed Data from NSDQ)

$10.07 USD

10.07
2,997,469

-0.46 (-4.37%)

Updated Aug 5, 2024 04:00 PM ET

After-Market: $10.08 +0.01 (0.10%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (91 out of 251)

Industry: Medical - Biomedical and Genetics

Better trading starts here.

Zacks News

Arpita Dutt headshot

Biotech Stock Roundup: Dynavax Vaccine Gets FDA Nod, Loxo Inks Deal with Bayer

Regulatory actions and licensing and collaboration agreements were the key highlights this week with companies like Loxo Oncology (LOXO) remaining in the limelight.

    Options Traders Expect Huge Moves in Dynavax (DVAX) Stock

    Dynavax (DVAX) needs investors to pay close attention to the stock based on moves in the options market lately.

      Arpita Dutt headshot

      Biotech Stock Roundup: Regeneron Delivers Strong Q3 Results, Cellectis Clinical Hold Lifted

      While focus remained on Regeneron's (REGN) Q3 earnings, Dicerna was also in the news related to its collaboration agreement with Boehringer Ingelheim.

        The Zacks Analyst Blog Highlights: Keryx Biopharmaceuticals, Bristol-Myers Squibb, Dynavax Technologies, Heron Therapeutics and Ultragenyx Pharmaceutical

        The Zacks Analyst Blog Highlights: Keryx Biopharmaceuticals, Bristol-Myers Squibb, Dynavax Technologies, Heron Therapeutics and Ultragenyx Pharmaceutical

          Arpita Dutt headshot

          5 Biotech and Pharma Stocks with Key FDA Catalysts this November

          Here is a look at five biotech and pharma stocks including Dynavax (DVAX) that have an important regulatory event lined up this month.

            Sweta Killa headshot

            Best Sector ETF of Q3 and its Top-Performing Stocks

            Inside the top performing stocks of top U.S.-focused ETF of Q3.

              Are Options Traders Betting on a Big Move in Dynavax (DVAX) Stock?

              Investors in Dynavax Technologies Corporation (DVAX) need to pay close attention to the stock based on moves in the options market lately.

                Arpita Dutt headshot

                Biotech Stock Roundup: Q2 Earnings from Regeneron, Kite & More, FibroGen Up on IPF Data

                Regeneron (REGN) and several other biotech companies reported Q2 earnings while FibroGen hit a 52-week high on promising idiopathic pulmonary fibrosis (IPF) data.

                  Dynavax Technologies (DVAX) Catches Eye: Stock Adds 11.2% in Session

                  Dynavax Technologies Corporation (DVAX) was a big mover last session, as the company saw its shares rise over 11% on the day.

                    Arpita Dutt headshot

                    Biotech Stock Roundup: Q2 Earnings from Gilead, CELG & More, Dynavax Up on Panel Vote

                    Companies like Gilead (GILD) topped expectations in the second quarter while Dynavax shot up on a positive FDA advisory panel vote.

                      Company News For August 1, 2017

                      Companies in the news are: DVAX,SNI,MDT,CAH,DISC,LH

                        Megan Sanks headshot

                        Dynavax (DVAX) Shares Jump 75% after FDA Committee Approval

                        Dynavax Technologies Corp. (DVAX) shares rocketed 75% in morning trading on Monday after a Food and Drug Administration committee approved the company's hepatitis B vaccination.

                          Options Traders Expect Huge Moves in Dynavax Technologies (DVAX) Stock

                          Dynavax Technologies (DVAX) needs Investors to pay close attention to the stock based on moves in the options market lately.

                            Dynavax Technologies (DVAX) Catches Eye: Stock Gains 6.6%

                            Dynavax Technologies Corporation (DVAX) shares rose almost 7% in the last trading session.

                              Dynavax (DVAX) Looks Good: Stock Gains 16.9% in Session

                              Dynavax Technologies Corporation (DVAX) moved big last session, as its shares rose almost 17% on the day.

                                Sanghamitra Saha headshot

                                Big Changes to BioShares Biotech ETFs: Who's In, Who's Out?

                                Inside the changes in portfolio constituents of two BioShares Biotech ETFs.

                                  Supriyo Bose headshot

                                  Why These 3 Healthcare Stocks Lost Half Their Value in November

                                  As the equity market braced itself for the Trump era, some healthcare stocks felt the tremors of his ensuing policy reforms and declined significantly in November.